Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy.
Journal: Cell metabolism
Published: August 30, 2023
A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration.
Journal: American journal of ophthalmology
Published: September 29, 2021
Ranibizumab Alters Levels of Intraocular Soluble Cytokine Receptors in Patients with Diabetic Macular Edema.
Journal: Current eye research
Published: September 07, 2019
Identification of VEGF-independent cytokines in proliferative diabetic retinopathy vitreous.
Journal: Investigative ophthalmology & visual science
Published: September 05, 2013
Showing 1-4 of 4
Last Updated: 09/26/2026